Evidence map›Paper›PMID 39487298›Full record

ArticleScientific reports2024

Prevalence and associated risk factors of prostate cancer among a large Chinese population.

Jun Chen, Liang He, Yixiu Ni, Feijun Yu, Aokang Zhang, Xing Wang, Junfeng Yan

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jun Chen *Urology, Zhejiang Hospital, No.12 lingyin Road, Hangzhou, 310013, China. phoebe84331@foxmail.com.
Liang He *Chronic disease department, Disease Control and Prevention Center of Zhuji, No.38, East Road, Jiyang Street, Zhuji, Shaoxing, 311800, China.
Yixiu Ni *Urology, Zhejiang Hospital, No.12 lingyin Road, Hangzhou, 310013, China.
Feijun YuUrology, Zhejiang Hospital, No.12 lingyin Road, Hangzhou, 310013, China.
Aokang ZhangUrology, Zhejiang Hospital, No.12 lingyin Road, Hangzhou, 310013, China.
Xing WangUrology, Zhejiang Hospital, No.12 lingyin Road, Hangzhou, 310013, China.
Junfeng YanUrology, Zhejiang Hospital, No.12 lingyin Road, Hangzhou, 310013, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is one of the most important health problems among elderly men in China, with the increasing aging of the population. A cross-sectional survey was conducted in eastern China from 2022 to 2023. Recruitment included a total of 70,342 participants aged 60 or older. Social demographic information, such as individual factors like age, education levels and behavior habits, physical examination and laboratory tests results were collected. Age-standardized prevalence rates were estimated by a direct method with a standard population. T test and chi-square test were used to compare the statistical differences. Multivariate regression models were used to identify the risk factors of PCa. Overall, the crude and age-standardized PCa prevalence is 0.93% and 0.91%, respectively in eastern China. When we adjusted all the co-variables, it showed that high age, smoking, having a higher BMI and higher CA19-9 were associated with a higher risk for a prostate cancer diagnosis. Faced with the demographic transition, innovative strategies are needed to control and prevent PCa. Conducting early screening among male population in community health service centers in eastern of China, especially among a population with associated risk factors such as high age, obesity, and conducting community-based intervention programs might be helpful to address this increasingly significant health problem.

Indexed as

Prostatic NeoplasmsAgedAged, 80 and overAge FactorsChinaCross-Sectional StudiesEast Asian PeopleHumansMaleMiddle AgedPrevalenceRisk Factors

Identifiers

PMID39487298
PMCPMC11530631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.